Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank18
3Y CAGR-70.7%
5Y CAGR-30.0%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
-70.7%/yr
vs +232.8%/yr prior
5Y CAGR
-30.0%/yr
Recent deceleration
Acceleration
-303.5pp
Decelerating
Percentile
P18
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.80M | -92.8% |
| 2024 | $38.91M | +49.6% |
| 2023 | $26.00M | -76.5% |
| 2022 | $110.78M | +30.2% |
| 2021 | $85.08M | +412.6% |
| 2020 | $16.60M | +148.6% |
| 2019 | $6.68M | +639.4% |
| 2018 | $903000.00 | +336.2% |
| 2017 | $207000.00 | -97.4% |
| 2016 | $8.08M | - |